Central nervous system drugs

Application Apyrase is used to hydrolyze nucleoside triphosphates and diphosphates. For hydrolysis of organic di and triphosphates, the optimal pH is 6, and for inorganic substrates, the optimal pH is 5.

Application Apyrase is used to hydrolyze nucleoside triphosphates and diphosphates. For hydrolysis of organic di and triphosphates, the optimal pH is 6, and for inorganic substrates, the optimal pH is 5.

Application Apyrase is used to hydrolyze nucleoside triphosphates and diphosphates. For hydrolysis of organic di and triphosphates, the optimal pH is 6, and for inorganic substrates, the optimal pH is 5.

Biochem/physiol Actions AR-R17779 is a nicotinic acetylcholine receptor alpha7 full agonist that targets &#945:7 nAChR with high affinity (Ki = 92 nM/rat &#945:7 against 5 nM &#945:-BTX vs.16 &#956:M/rat &#945:4&#946:2 against 3 nM (-)-nicotine)

Biochem/physiol Actions AR-R17779 is a nicotinic acetylcholine receptor alpha7 full agonist that targets &#945:7 nAChR with high affinity (Ki = 92 nM/rat &#945:7 against 5 nM &#945:-BTX vs.16 &#956:M/rat &#945:4&#946:2 against 3 nM (-)-nicotine)

Arachidonamide (20:4, n-6) is a weak cannabinoid CB1 and CB2 agonist.

Arachidonamide (20:4, n-6) is a weak cannabinoid CB1 and CB2 agonist.

Arachidonic acid leelamide is the arachidonic amide analog of leelamine. Leelamine has weak affinity for the human CB1 and CB2 receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 &microM.

Arachidonic acid leelamide is the arachidonic amide analog of leelamine. Leelamine has weak affinity for the human CB1 and CB2 receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 &microM.

Arachidonic acid leelamide is the arachidonic amide analog of leelamine. Leelamine has weak affinity for the human CB1 and CB2 receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 &microM.

Arachidonic acid is the keystone essential fatty acid at the origin of the arachidonic acid cascade. It is converted by cyclooxygenase, lipoxygenase, and epoxygenase enzymes into more than one hundred fifty different potent primary autacoid

Arachidonamide is an analog of AEA that lacks the hydroxyethyl moiety. It is hydrolyzed by FAAH more effectively than AEA but exhibits significantly weaker binding to the human CB1 receptor with a Ki value of 9.